Biological activities of thymosin β4 defined by active sites in short peptide sequences

FASEB Journal

Volumn 24, Issue 7, 2010, Pages 2144-2151

  Sosne, Gabriel ^a   Qiu, Ping ^b   Goldstein, Allan L ^b   Wheater, Michelle ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF DETROIT MERCY   (United States)

Author keywords

Angiogenesis; Apoptosis; Inflammation; Wound healing

Indexed keywords

THYMOSIN BETA4;

AMINO ACID SEQUENCE; ANGIOGENESIS; APOPTOSIS; CELL MIGRATION; CELL SURVIVAL; EXOCYTOSIS; FIBROGENESIS; HAIR GROWTH; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE REPAIR; WOUND HEALING;

ANIMALS; CATALYTIC DOMAIN; HUMANS; PEPTIDES; THYMOSIN;

EUKARYOTA;

EID: 77954447831     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-142307     Document Type: Review

References (70)

1. Goldstein, A. L., Hannappel, E., and Kleinman, H. K. (2005) Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 11, 421-429 (Pubitemid 41254045)
2. Mannherz, H. G., and Hannappel E. (2009) The beta thymosins: Intracellular and extracellular activities of a versatile actin binding protein family. Cell Motil. Cytoskeleton 66, 839-851
3. Goldstein, A. L., Slater, F. D., and White, A. (1966) Preparation, assay, and partial purification of the thymic lymphocytopoietic factor (thymosin). Proc. Natl. Acad. Sci. U. S. A. 56, 1010-1017
4. Safer, D., Elzinga, M., and Nachmias, V. T. (1991) Thymosin beta 4 and Tx, an actin-sequestering peptide, are indistinguishable. J. Biol. Chem. 266, 4029-4032 (Pubitemid 21909312)
5. Malinda, K. M., Goldstein, A. L., and Kleinman, H. K. (1997) Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 11, 474-481 (Pubitemid 27259989)
6. Fan, Y., Gong, Y., Ghosh, P. K., Graham, L. M., and Fox, P. L. (2009) Spatial coordination of actin polymerization and ILKAkt2 activity during endothelial cell migration. Dev. Cell 16, 661-674
7. Ito, M., Iguchi, K., Usui, S., and Hirano, K. (2009) Overexpression of thymosin β4 increases pseudopodia formation in LNCaP prostate cancer cells. Biol. Pharm. Bull. 32, 1101-1104
8. 4 promotes tumor metastasis by stimulating migration and inducing angiogenesis through increased expression of vascular endothelial growth factor. J. Natl. Cancer Inst. 95, 1674-1680
9. 4 promotes angiogenesis. FASEB J. 17, 2103-2105
10. Grant, D. S., Kinsella, J. L., Kibbey, M. C., LaFlamme, S., Burbelo, P. D., Goldstein, A. L., and Kleinman, H. K. (1995) Matrigel induces thymosin beta4 gene in differentiating endothelial cells. J. Cell Sci. 108, 3685-3694 (Pubitemid 26003202)
11. Malinda, K., Goldstein, A. L., and Kleinman, H. K. (1999) Thymosin beta 4 accelerates wound healing. J. Invest. Dermatol. 113, 364-368 (Pubitemid 29449075)
12. Li, X., Zheng, L., Peng, F., Qi, C., Zhang, X., Zhou, A., Liu, Z., and Wu, S. (2007) Recombinant thymosin beta 4 can promote full thickness cutaneous wound healing. Protein. Expr. Purif. 56, 229-236 (Pubitemid 350011045)
13. Sosne, G., Chan, C. C., Thai, K., Kennedy, M., Szliter, E. A., Hazlett, L. D., and Kleinman, H. K. (2001) Thymosin beta4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp. Eye Res. 72, 605-608 (Pubitemid 32977230)
14. Sosne, G., Szliter, E. A., Barrett, R., Kernacki, K. A., Kleinman, H., and Hazlett, L. D. (2002) Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp. Eye Res. 74, 293-299 (Pubitemid 34948404)
15. 4 increases hair growth by the activation of clonogenic hair follicle stem cells. FASEB J. 18, 385-387
16. Smart, N., Risebro, C. A., Melville, A. A. D., Moses, K., Schwartz, R. J., Chien, K. R., and Riley, P. R. (2007) Thymosin beta 4 induces adult epicardial progenitor mobilization and neovascularization. Nature 44, 177-182 (Pubitemid 46095717)
17. 4 is an essential paracrine factor of embryonic endothelial progenitor cell mediated cardioprotection. Circulation 117, 2232-2240
18. Qui, P., Kurpas-Wheater, M., and Sosne, G. (2007) Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration. J. Cell. Physiol. 212, 165-173
19. 4 promotes matrix metalloproteinase expression during wound repair. J. Cell. Physiol. 208, 195-200
20. So, I. S., Partk, S. Y., and Kim, I. S. (2008) Thymosin beta4 is involved in stabilin-2-mediated apoptotic cell engulfment. FEBS Lett. 582, 2161-2166
21. Lee, H.R., Yoon, S. Y., Kang, H. B., Park, S., Kim, K. E., Cho, Y. H., Kim, S., Kim, C. W., Cho, B. J., Lee, W. J., Bang, S. I., Park, H., Cho, D. (2009) Thymosin beta 4 enhances NK cell cytotoxicity mediated by ICAM-1. Immunol. Lett., 123, 72-76
22. Sosne, G., Siddiqi, A., and Kurpas-Wheater, M. (2004) Thymosin beta 4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest. Opthalmol. Vis. Sci. 45, 1095-1200 (Pubitemid 38869013)
23. Bock-Marquette, I., Saxena, A., White, M. D., DiMaio, M., and Srivastava, D. (2004) Thymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration, survival, and cardiac repair. Nature 432, 466-472 (Pubitemid 39576522)
24. Ho, J. H., Tseng, K. C., Ma, W. H., Chen, K. H., Lee, O. K., and Su, Y. (2008) Thymosin beta 4 upregulates anti-oxidative enzymes and protects human corneal epithelial cells against oxidative damage. Br. J. Opthalmol. 92, 992-997
25. 4 reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int. Immunol. 3, 1225-1233
26. Hofer, S., Brenner, T., Bopp, c., Steppan, J., Lichtenstern, C., Weitz, J., Bruckner, T., Martin, E., Hoffmann, U., and Weigand, M.A. (2009) Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction. Crit. Care 13, R93
27. Sosne, G., Xu, L., Prach, L., Mrock, L. K., Kleinman, H. K., Letterio, J., Hazlett, L. D., and Kurpakus-Wheater, M. (2004) Thymosin beta-4 stimulates laminin-5 production independent of TGF-beta. Exp. Cell Res. 293, 175-183 (Pubitemid 38064424)
28. Li, Y., Wang, G., Yu, H., Yang, X., Xu, S., Nie, L., and Che, Y. (2008) Expression of laminin-5 in rat skin wounds regulated by recombinant thymosin beta 4. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22, 1306-1310
29. Wynn, T. A. (2008) Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210
30. Kraehenbuehl, T. P., Ferreira, L. S., Zammaretti, P., Hubbell, J. A., and Langer R. (2009) Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 30, 4318-4324
31. Hu, S-K., Low, T. L. K., and Goldstein, A. L. (1981) Modulation of terminal deoxynucleotidyl transferase activity by thymosin. Mol. Cell. Biochem. 41, 49-58 (Pubitemid 12142400)
32. Pazmino, N. H., Ihle, J. N., Goldstein, A. L. (1978) Induction in vivo and in vitro of terminal deoxynucleotidyl transferase by thymosin in bone marrow cells from athymic mice. J. Exp. Med. 147, 708-718
33. Border, B., Lin, S. C., Griffin, W. W., Pardues, S., and Morrison-Bogorad, M. (1993) Alterations in actin-binding beta thyosin expression accompany neuronal differentiation and migration in rat cerebellum. J. Neurochem. 61, 2104-2114 (Pubitemid 2012500)
34. Leonard, D. G. B., Ziff, E. S., and Greene, L. A. (1987) Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells. Mol. Cell. Biol. 7, 3156-3167
35. Vartianen, N., Pyykonen, I., Hokfelt, T., and Koistinaho, J. (1996) Induction of thymosin beta 4 mRNA following focal brain ischemia. NeuroReport. 7, 1613-1616 (Pubitemid 26332334)
36. 4 in experimental models of excitotoxicity. Ann. N. Y. Acad. Sci. 1112, 219-224
37. Yang, H., Cheng, X., Yao, Q., Li, J., and Ju, G. (2008) The promotive effects of thymosin beta 4 on neuronal survival and neurite outgrowth by upregulating L1 expression. Neurochem. Res. 33, 2269-2280
38. Zhang J, Zhang, Z. G., Morris, D., Li, Y. Elias, S. B., and Chopp, M. (2009) Neurological functional recovery after thymosin beta 4 treatment in mice with experimental auto encephalomyelitis. Neuroscience 164, 1887-1893
39. Sosne, G., Qui, P., and Kurpakas-Wheaater, M. (2007) Thymosin beta 4 and the eye: I can see clearly now. Ann. N. Y. Acad. Sci. 1112, 114-122
40. Sosne, G., Qui, P., Christopherson, P. L., and Wheater, M. K. (2007) Thymosin beta 4 suppression of corrneal NFKappaB: a potential anti-inflammatory pathway. Exp. Eye Res. 84, 663-669 (Pubitemid 46420439)
41. Bock-Marquette, I., Shrivastava, S., Pipes, G. C. T., Thatcher, J. E., Blystone, A., Shelton, J. M., Galindo, C. L., Melegh, B., Srivastava, D., Olson, E. N., and DiMaio, J. M. (2009) Thymosin beta 4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial cell activation in adult mice in vivo. J. Mol. Cell. Cardiol. 46, 728-738
42. Young, D. J., Lawrence, A. J., mac Lean, A. G., Leung, B. P., McInnes, I. B., Canas, B., Pappin, D. J., and Stevenson, J. D. (1999) Thymosin beta 4 sulfoxidee is an anti inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med. 5, 1424-1427
43. Kupatt, C., Bock-Marquette, I., and Boekstegers, P. (2008) Embryonic endothelial progenitor cell-mediated cardioprotection requires thymosin beta 4. Trends Cardiovasc. Med. 18, 205-210
44. Cavasin, M. S. (2006) Therapeutic effect of thymosin beta 4 and its derivative N-acetyl-seryly-aspartyl-lysyl-proline (Ac-SDKP) on cardiac healing after infarction. Am. J. Cardiovasc. Drugs 6, 305-311
45. Morianu, J., Fett, J. W., Riordan, J. F., and Vallee, B. L. (1993) Actin is a surface component of calf pulmonary artery endothelial cells in culture. Proc. Natl. Acad. Sci. U. S. A. 90, 3815-3819
46. Huang, C. M., Wang, C. C., Barnes, S., and Elmets, V. A. (2006) In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteonomics. Proteonomics 6, 5805-5814 (Pubitemid 44764017)
47. Breiger, A., Plotz, G., Zeuzem, S., and Trojan, J. (2007) Thymosin beta 4 expression and nuclear transport are regulated by hMLH1. Biochem. Biophys. Res. Commun. 364, 731-736
48. Bednarek, R., Boncel, J., Smolarczyk, K., Cierniewska-Cieslak, A., Wyroba, E., and Cierniewski, C. S. (2008) Ku80 as novel receptor for thymosin beta 4 that mediates its intracellular activity different from G-actin sequestering. J. Biol. Chem. 283, 1534-1544
49. Huff, T., Rosorius, O., Ottan, A. M., Muller, C. S., Ballweber, E., Hannappel, E., and Mannherz, H. G. (2004) Nuclear localization of the G-actin sequestering peptide thymosin beta 4. J. Cell Sci. 117, 5333-5341
50. Azizi, M., Ezan, E., Nicolet, L., Grognet, J. M., and Menard, J. (1997) High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. Hypertension 30, 1015-1019
51. Cavasin, M. A., Rhaleb, N. E., Yang, X. P., and Carretero, O. A. (2004) Prolyly oligopeptidase is involved in release of the anti fibrotic peptide As-SDKP. Hypertension 43, 1140-1145
52. Cingolani, O. H., Yang, X-P., Liu Y-H., Villanueva, M., Rhaleb, N. E., and Carretero, O. A. (2004) Reduction of cardiac fibrosis decreases systolic performance with an affect on diastolic function in hypertensive rats. Hypertension 43, 1067-1073
53. Guigon, M., Bonnet, D., Lemoine, F. M., Kobari, L., Permentier, C., Mary, J. Y., and Najman, A. (1990) Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp. Hematol. 18, 1112-1115
54. Bonnet, D., Lemoine, F. M., Pontvert-Deluq, S., Baillou, C., Najman, A., and Guigon, M. (1993) Direct and reversible inhibitory effect of the tetrapeptide acetylN-ser-asp-lys- pro (seraspenide) on the growth of human CD34+ subpopulations in response to growth factors. Blood 82, 3307-3314
55. Wang, D., Carretero, O. A., Yang, X. Y., Rhaleb, N. E., Liu, Liao, Y. H., T.D., and Yang, X. P. (2004) N-acetyl-seryl-aspartyl-lysylproline stimulates angiogenesis in vitro and in vivo. Am. J. Phyiol. Heart. Circ. Physiol. 287, H209-H205
56. Yang, F., Yang, X. P., Liu, Y. H., Xu, J., Cingolani, O., Rhaleb, N. E., and Carretero, O. A. (2003) AcSDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Hypertension 43, 229-236
57. Kanasaki, K., Haneda, M., Sugimoto, T., Shibya, K., Isono, M., Isshiki, K., Araki, S., Uzu, T., Kashiwagi, A., and Koya, D. (2006) N-acetyl-seryl- aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via upregulation of cell cycle modulators. Biochem. Biophys. Res. Commun. 342, 758-765
58. Lin, C. X., Rhaleb, N. E., Yang, X. P., Liao, T. D., D'Ambrosio, M. A., and Carretero, O. A. (2008) Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiogentisn II-induced hypertension. Am. J. Phyiol. Heart. Circ. Physiol. 295, H1253-H1261
59. Shibya, K., Kanasaki, M., Isono, H., Sato, M., Omata, T., Sugimoto, S., Araki, K., Isshiki, A., Kashiwagi, M., Haneda, D., and Koya, D. (2005) N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes 54, 838-845
60. Peng, H., Carretero, O. A., Raji, L., Yang, F., Kapke, A., and Rhaleb, N. E. (2001) Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-prline on the heart and kidney in aldosterone-salt hyptensive rats. Hypertension 37, 794-800
61. Giradi, M., Sherling, M. A., Filler, R. B., Shires, J., Theodoridis, E., Hayday, A. C., Tigelaar, R. E. (2003) Anti-inflammatory effects in the skin of thymosin beta4 splice variants. Immunology 109, 1-7
62. Sharma, U., Rhaleb, N. E., Pokharel, S., Harding, P., Rasoul, S., Peng, H., and Carretero, O. A. (2008) Novel anti-inflammatory mechanisms of N-acetyl ser-asp-lys-pro in hypertension-induced target organ damage. Am. J. Physiol. Heart Circ. Physiol. 294, H1226-H1232
63. Volkov, Quere, L., P., Coudert, F., Compte, L., Antipov, Y., and Praloran, V. (1996) the tetrapeptide AcSDKP, a negative regulator of cell cycle entry, inhibits the proliferation of human and chicken lymphocytes. Cell. Immunol. 168, 302-302
64. Cavasin, M. A., Lioa, T. D., Yang, X. Z. P., Yang, J. J., and Carretero, O. A. (2007) Decreased endogenous levels of Ac-SDKP promote organ fibrosis. Hypertension 50, 130-156
65. Cavasin, M. A., Liao, T. D., Yang, X. P., Yang, J. J., and Carretero, O. A. (2007) Decreased endogenous levels of Ac-SDKP promote organ fibrosis. Hypertension 50, 130-136
66. Pokharel, S., Rasoul, Roks, S., A. J. M., van Leeuwen, R. E. W., Van Luyn, M. J. A., Deelman, L. E., Smits, J. F., Carretero, O. A., van Gilst, W. H., and Pinto, Y. M. (2002) N- acetyl-ser-asp-lys-pro inhibits phosphorylation of Smad2 in cardiac fibroblasts. Hypertension 40, 155-161
67. Kanasaki, K., Koya, D., Sugimoto, T., Isono, M., Kashiwagi, A., and Haneda, M. (2002) N-acetyl seryl-aspartyl-lysly-proline inhibits TGF-beta mediated plasminogen activator inhibitor-1 expression via an inhibition of the Smad pathway in human mesangial cells. Am. Soc. Nephrol. 14, 863-872
68. Wyczoikowska, J., Walczak-Drzewiecka, A., Wangner, W., and Dastych, J. (2007) Thymosin beta 4 and thymosin beta 4-derived peptides induce mast cell exocytosis. Peptides 28, 752-759
69. Leeananasakisiri, W., Desimone, S. K., Huff, T., Hannappel, E., and Huff, T. F. (2004) Thymosin beta 4 and its N-terminal tetrapeptide, AcSDKP, inhibit proliferation, and induce dysplastic, non-apoptotic nuclei and degranulation of mast cells. Chem. Biodivers. 1, 1091-1100
70. Philp, D., Badamchian, M., Scheremta, B., Nguyen, M., Goldstein, A. L., and Kleinman, H. K. (2003) Thymosin beta 4 and a synthetic peptide containing the actin- binding domain promote dermal wound repair in db/db mice and in aged mice. Wound Repair Regen. 11, 19-24